Crescina Follicular Islands Re-Growth 2100 Hair-Loss Woman Vials 20's
Crescina Follicular Islands Re-Growth 2100 Hair-Loss Woman Vials 20's est en rupture de stock et sera expédié dès qu’il sera de retour en stock.
Impossible de charger la disponibilité pour le Service de retrait
Product Overview:
Crescina Hair Follicular Islands is a high-performance topical treatment in ampoule form designed to support hair growth and combat thinning. Utilizing the patented Crescina Re-Growth formula, this treatment is enriched with cysteine, lysine, and glycoproteins. These components are delivered through a cyclodextrin-based system for sustained release. The formula also includes a specialized complex to target and assist both primary and secondary hair follicles within the follicular islands, promoting healthy hair development.
Key Ingredients:
- Cysteine
- Lysine
- Glycoproteins
- Stem Engine - HFSC Formula
- Cyclodextrins (for gradual release)
-
Swiss Follicular Islands Complex:
- Glycogen
- Glutamyl-amido-ethyl-indole
- Lupinus albus
- Proline
- Extracts of Triticum vulgare (Wheat), Glycine max (Soybean), and Scutellaria baicalensis (Baikal Skullcap)
Benefits:
- Supports Hair Growth: Aids in the physiological growth and development of hair follicles.
- Targets Follicular Islands: Helps both primary and secondary follicles within the follicular islands.
- Non-Effect on Atrophied Follicles: Does not affect fully atrophied hair bulbs and follicles.
How to Apply:
- Initial Treatment: Use one 3.5 ml ampoule per day for five consecutive days.
- Rest Period: Follow with a two-day rest period.
- Ongoing Use: Continue treatment as per the instructions on the package.
- Packaging: Comes in a pack of 20 ampoules, providing a one-month supply.
FAQs:
- What is the recommended duration of treatment? A minimum of two months is advised.
- How often should the ampoule be applied? Apply one ampoule daily for five days, then take a two-day break.
- Is this treatment suitable for all types of hair loss? It is indicated for physiological and non-pathological thinning but does not act on completely atrophied follicles.